(Q46606214)

English

Entecavir therapy for up to 96 weeks in patients with HBeAg-positive chronic hepatitis B.

scientific article published on 14 August 2007

In more languages
default for all languages
No label defined

No description defined

Statements

Entecavir therapy for up to 96 weeks in patients with HBeAg-positive chronic hepatitis B. (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit